Literature DB >> 17405975

News about influenza B drug resistance that cannot be ignored.

Anne Moscona, Jennifer McKimm-Breschkin.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17405975     DOI： 10.1001/jama.297.13.1492

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

Review 1.  Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance.

Authors:  Jennifer L McKimm-Breschkin
Journal:  Influenza Other Respir Viruses       Date:  2013-01       Impact factor: 4.380

2.  Meeting report: risk assessment of tamiflu use under pandemic conditions.

Authors:  Andrew C Singer; Bruce M Howard; Andrew C Johnson; Chris J Knowles; Simon Jackman; Cesare Accinelli; Anna Barra Caracciolo; Ian Bernard; Stephen Bird; Tatiana Boucard; Alistair Boxall; Jayne V Brian; Elise Cartmell; Chris Chubb; John Churchley; Sandra Costigan; Mark Crane; Michael J Dempsey; Bob Dorrington; Brian Ellor; Jerker Fick; John Holmes; Tom Hutchinson; Franz Karcher; Samuel L Kelleher; Peter Marsden; Gerald Noone; Miles A Nunn; John Oxford; Tony Rachwal; Noel Roberts; Mike Roberts; Maria Ludovica Saccà; Matthew Sanders; Jürg Oliver Straub; Adrian Terry; Dean Thomas; Stephen Toovey; Rodney Townsend; Nikolaos Voulvoulis; Chris Watts
Journal:  Environ Health Perspect       Date:  2008-05-30       Impact factor: 9.031

3.  Antiviral oseltamivir is not removed or degraded in normal sewage water treatment: implications for development of resistance by influenza A virus.

Authors:  Jerker Fick; Rickard H Lindberg; Mats Tysklind; Paul D Haemig; Jonas Waldenström; Anders Wallensten; Björn Olsen
Journal:  PLoS One       Date:  2007-10-03       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.